Germany - s Merck in 54m Swedish generics buy
502454
The deal, which must be approved by regulators, will make the German group the number one generics company in Scandinavia, a growing market worth about 600m last year, according to Merck.
138327
Swiss biotech company Addex Pharmaceuticals SA  could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug for schizophrenia, it said on Thursday.
227114
ROMA, 30 SET - L&#39;azienda farmaceutica Merck &amp; Co. Inc ha annunciato il ritiro volontario, anche in Italia, del medicinale Vioxx. Il farmaco, indicato per il trattamento dell&#39;artrite, e&#39; un antidolorifico di largo consumo.
196912
Nonbinding offers for the generics  business of Merck KGaA , worth at least 4 billion  euros ($5.3 billion), are due on Monday, a source close to the  sale process told Reuters, confirming a newspaper report.
562425
German industrial conglomerate MAN AG   will offer cash and shares to buy Scania AB (SCVb.ST)  in a bid that values the Swedish truckmaker at 9.6 billion  euros ($12.2 billion) in total, MAN said early on Monday.
254545
An Indian drug maker, Ranbaxy Laboratories, said it had submitted a bid for the generics unit of the German drug maker Merck but did not disclose how much it was offering. Analysts say Merckâs generics unit could be worth as much as 5 billion euros ($6.6 billion). Merck said last month that it had started contacting companies that might be interested in acquiring its generics drugs unit. Two companies, Ranbaxy and the Actavis Group of Iceland, have publicly expressed an interest. Merck is based in Darmstadt.
287707
Serono SA , one of the world's largest biotechnology companies, was bought yesterday by German chemical giant Merck KGaA in a deal worth more than $13 billion.
751178
ZURICH/FRANKFURT  - German drugmaker Merck KGaA   MRCG.DE on Thursday unveiled a surprise 16.6-billion-Swiss   franc ($13.26-billion) deal to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
725625
German chemicals and pharmaceuticals giant Bayer says it is still open to further acquisitions even though it was still in the process of integrating Berlin-based drug maker Schering which it recently acquired for close to 17 billion euros (22 billion dollars).
279752
NEW YORK, December 3  - Biomiraâs (BIOM.NAS) share price appreciated 94% in mid day trade on the NASDAQ today, after the Canadian biotech company, along with its German development partner, Merck KgaA (MRK), reported promising test
288984
Spectrum Pharmaceuticals SPPI.O said  on Friday U.S. regulators have approved its generic version of  Bayer's BAYG.DE  Cipro antibiotic, triggering a $750,000  equity investment by one of its partners.
140665
Merck KGaA, the German drug and chemical company whose products include the multiple sclerosis drug Rebif and cancer treatment Erbitux, said Monday that its fourth-quarter profit soared to nearly $5 billion as it reaped the benefits of its acquisition of Serono and the divestiture of its generic drug unit.
219582
Stampa Usa, Glaxosmithkline interessata ad acquisto
44626
Costs associated with taking over a Swiss rival dent net profits at German drug firm Merck.
480970
Swiss biotech company Addex Pharmaceuticals SA  said it could receive more than $700 million from Merck & Co Inc  for a licensing deal on its ADX63365 drug to treat schizophrenia, lifting its shares.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
457209
Akzo Nobel  said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough  for 11 billion euros ($14.4 billion), in a last-minute reversal of plans to float it on the stock market.